Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Bill taking aim at anti-competitive pharmaceutical pricing passes Oregon Senate
The Oregon Senate passed a bill on Thursday intended to stop an anti-competitive practice used by pharmaceutical companies.
THE ISSUE: Prescription drugs are increasingly unaffordable.
THE BILL: Senate Bill 764
WHAT IT DOES: Allows the Oregon attorney general to take action against pharmaceutical companies that use agreements to stifle competition.
WHY IT WAS PROPOSED: According to state Sen. Deb Patterson, D-Salem, pharmaceutical companies take legal action against competitors who may be developing a generic version of a drug. As part of the settlement agreement, the pharmaceutical company pays its competitor not to develop the generic version of the drug.
Read more: https://www.salemreporter.com/blogs/174/#4106